1887

Abstract

The Epstein—Barr virus (EBV) open reading frame (ORF) BCRF1, expressed in the late phase of the viral cycle, encodes a homologue of human interleukin-10 (hIL-10). Unspliced, 3′ co-terminal transcripts of 0.8 and 1.6 kb from -tetradecanoylphorbol 13-acetate (TPA)-treated B95-8 cells have been described but other results indicated the existence of uncharacterized transcript(s) initiated upstream of the 1.6 kb BCRF1 mRNA. Here we describe two additional large transcripts of the BCRF1 ORF, a possibly spliced product of 3.5 kb and an unspliced product of 4.5 kb. The time course of the expression of BCRF1 transcripts and of the secreted protein from Akata cells were also determined.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-6-1163
1996-06-01
2022-10-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/6/JV0770061163.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-6-1163&mimeType=html&fmt=ahah

References

  1. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Seguin C., Tuffnell P. S., Barrell B. G. 1984; DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207–211
    [Google Scholar]
  2. Giot J.-F., Mikaelian I., Buisson M., Manet E., Joab I., Nicolas J.-C., Sergeant A. 1991; Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. Nucleic Acids Research 19:1251–1258
    [Google Scholar]
  3. Hudson G. S., Bankier A. T., Satchwbll S. C., Barrell B. G. 1985; The short unique region of the B95-8 Epstein-Barr virus genome. Virology 147:81–98
    [Google Scholar]
  4. Lau R., Middeldorp J., Farell P. J. 1993; Epstein-Barr virus gene expression in oral hairy leukoplakia. Virology 195:463–474
    [Google Scholar]
  5. Lotz M., Tsoukas C. D., Fong S., Carson D. A., Vaughan J. H. 1985; Regulation of Epstein-Barr virus infection by recombinant interferons selected sensitivity to interferon-γ . European Journal of Immunology 15:520–525
    [Google Scholar]
  6. Moore K. W., O’Garra A., De Waal Malefyt R., Vieira P., Mosmann T. R. 1993; Interleukin-10. Annual Review of Immunology 11:165–90
    [Google Scholar]
  7. Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Bancherau J. 1992; Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proceedings of the National Academy of Sciences, USA 89:1890–1893
    [Google Scholar]
  8. Stewart J. P., Behm F. G., Arrand J. R., Rooney C. M. 1994; Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines. Virology 200:724–732
    [Google Scholar]
  9. Takada K., Ono Y. 1989; Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. Journal of Virology 63:445–449
    [Google Scholar]
  10. Vieira P., De Waal-Malefyt R., Dang M. N., Johnson K. E., Kastelein R., Fiorentino D. F., Devries J. E., Roncarolo M. G., Mosmann T. R., Moore K. W. 1991; Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFL. Proceedings of the National Academy of Sciences, USA 88:1172–1176
    [Google Scholar]
  11. Yates J. L., Warren N., Reisman D., Sugden B. 1984; A cisacting element from the Epstein-Barr virus genome that permits stable replication of recombinant plasmids in latently infected cells. Proceedings of the National Academy of Sciences, USA 81:3806–3810
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-6-1163
Loading
/content/journal/jgv/10.1099/0022-1317-77-6-1163
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error